ReviewInternational journal of molecular sciences2021

Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention.

Felipe V Gomes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.